Masachika Ikegami

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Locally Advanced

Top Venues

Cancer research

Japanese journal of clinical oncology

Genes, chromosomes & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Birgit Wilding, Lydia Woelflingseder, Anke Baum, Krzysztof Chylinski, Gintautas Vainorius, Neil Gibson, Irene C Waizenegger, Daniel Gerlach, Martin Augsten, Fiona Spreitzer, Yukina Shirai, Masachika Ikegami, Sylvia Tilandyova, Dirk Scharn, Mark A Pearson, Johannes Popow, Anna C Obenauf, Noboru Yamamoto, Shunsuke Kondo, Frans L Opdam, Annemarie Bruining, Shinji Kohsaka, Norbert Kraut, John Victor Heymach, Flavio Solca, Ralph A Neumuller
Zongertinib (BI 1810631), an irreversible HER2 TKI, spares EGFR signaling and improves therapeutic response in preclinical models and patients with HER2-driven cancers. Cancer discovery (2024)
Kazunori Senga, Masachika Ikegami, Sora Koiwa, Akihiro Takamiya, Toru Motoi
Calcified deep somatic soft tissue leiomyoma of the leg: A case report. SAGE open medical case reports 11 (2023)
Takao Mochizuki, Masachika Ikegami, Toru Akiyama
Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database. Cancer science 115 (2) (2023)
Takao Mochizuki, Masachika Ikegami, Toru Akiyama
Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database. Cancer science 115 (2) (2023)
Hiroshi Kobayashi, Liuzhe Zhang, Koichi Okajima, Yuki Ishibashi, Toshihide Hirai, Yusuke Tsuda, Masachika Ikegami, Hidenori Kage, Aya Shinozaki-Ushiku, Katsutoshi Oda, Sakae Tanaka
BRAF mutations and concurrent alterations in patients with soft tissue sarcoma. Genes, chromosomes & cancer (2023)
Masachika Ikegami
Prognostic benefit of comprehensive genomic profiling in clinical practice remains uncertain. Cancer science (2023)
Takao Mochizuki, Masachika Ikegami, Toru Akiyama
Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database. Cancer science 115 (2) (2023)
Masachika Ikegami
Letter to the editor: left-truncation bias should be considered in prognostic analysis using National Genomic Profiling Database. Japanese journal of clinical oncology (2023)
Takao Mochizuki, Masachika Ikegami, Toru Akiyama
Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database. Cancer science (2023)
Sho Mizuno, Masachika Ikegami, Takafumi Koyama, Kuniko Sunami, Dai Ogata, Hidenori Kage, Mitsuru Yanagaki, Hiroshi Ikeuchi, Toshihide Ueno, Michihiro Tanikawa, Katsutoshi Oda, Yutaka Osuga, Hiroyuki Mano, Shinji Kohsaka
High-throughput functional evaluation of MAP2K1 variants in cancer. Molecular cancer therapeutics (2022)
Taichi Tamura, Masachika Ikegami, Yusuke Kanemasa, Makiko Yomota, Akiko Furusawa, Ryohei Otani, Chiaki Saita, Ichiro Yonese, Tomoko Onishi, Hiroshi Kobayashi, Toru Akiyama, Tatsu Shimoyama, Tomoyuki Aruga, Tatsuro Yamaguchi
Selection bias due to delayed comprehensive genomic profiling in Japan. Cancer science (2022)
Junya Tabata, Takashi Nakaoku, Mitsugu Araki, Ryunosuke Yoshino, Shinji Kohsaka, Ayaka Otsuka, Masachika Ikegami, Ayako Ui, Shin-Ichiro Kanno, Keiko Miyoshi, Shigeyuki Matsumoto, Yukari Sagae, Akira Yasui, Masakazu Sekijima, Hiroyuki Mano, Yasushi Okuno, Aikou Okamoto, Takashi Kohno
Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis. Cancer research 82 (20) (2022)
Masachika Ikegami, Shinji Kohsaka, Takeshi Hirose, Toshihide Ueno, Satoshi Inoue, Naoki Kanomata, Hideko Yamauchi, Taisuke Mori, Shigeki Sekine, Yoshihiro Inamoto, Yasushi Yatabe, Hiroshi Kobayashi, Sakae Tanaka, Hiroyuki Mano
MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples. Communications biology 4 (1) (2021)